Eva Madsen

Eva Madsen is a researcher in the Department of Surgery at Erasmus MC, specializing in surgical oncology with a focus on peritoneal surface malignancies. Her research integrates clinical outcomes, genomic analysis, and advanced imaging techniques to improve treatment strategies for patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC).

Her research interests include:

• Cytoreductive Surgery (CRS) and HIPEC
• Peritoneal metastases from colorectal and breast cancer
• Pseudomyxoma peritonei
• Peritoneal mesothelioma
• Body composition analysis using CT imaging
• Intraperitoneal pharmacokinetics of chemotherapy agents

The recent publications show a strong trend toward improving clinical outcomes, optimizing drug delivery, and leveraging imaging and genomics for personalized oncological care. Her work frequently appears in high-impact surgical and oncological journals, reflecting active engagement in national and international collaborative research.

Scientific contributions include:

• Development of the Dutch CRS-HIPEC quality registry
• Genomic profiling of rare peritoneal tumors
• Validation of automated CT segmentation tools
• Pharmacokinetic studies of intraperitoneal chemotherapy

Eva Madsen collaborates extensively with surgical oncologists, medical oncologists, pathologists, and pharmacologists. She contributes to national initiatives aimed at standardizing and improving access to complex cancer surgeries. While no formal students or grants are listed, her role in multi-center studies suggests involvement in supervised research and collaborative funding efforts.